Home › Funds › Pentwater Capital Management LP › SGRY

Pentwater Capital Management LP position in SGRY

SURGERY PARTNERS INC · Health Care

Pentwater Capital Management LP reported holding 11,630,000 shares of SGRY (SURGERY PARTNERS INC) in its Q2 2026 13F filing — a position valued at US$195.4M, representing 2.27% of its reported portfolio and ranking #12 among its reported holdings. Pentwater Capital Management LP has disclosed SGRY holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)11.63M sh
Reported value held$195.38M
Portfolio Weight2.27%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Pentwater Capital Management LP's SGRY position evolved

Pentwater Capital Management LP first disclosed a stake in SGRY in Q4 2024 at 425,000 shares (US$9.0M). The position peaked in Q3 2025 at 11,681,000 shares, worth US$252.8M. Across 7 filings, Pentwater Capital Management LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 11,630,000 shares valued at US$195.4M — a reduction of -1,025,000 shares quarter over quarter.. Notable position changes include a 545% increase in Q1 2025 (shares fell 6% over the following quarter), a 155% increase in Q2 2025 (shares fell 3% over the following quarter), a 67% increase in Q3 2025 (shares fell 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 425.00K $9.00M New
Q1 2025 2.74M $65.12M Add
Q2 2025 7.00M $155.61M Add
Q3 2025 11.68M $252.78M Add
Q4 2025 10.00M $154.50M Reduce
Q1 2026 12.65M $150.85M Add
Q2 2026 11.63M $195.38M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SGRY and 13F data

SGRY (SURGERY PARTNERS INC) is a Health Care company. 33 other funds we track also report a position in SGRY — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$839.1M), KING STREET CAPITAL MANAGEMENT, L.P. (US$101.8M), Davidson Kempner Capital Management (US$56.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SGRY

All SGRY fund holders →

FAQ

How long has Pentwater Capital Management LP held SGRY?

Pentwater Capital Management LP has disclosed SGRY holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Pentwater Capital Management LP's current position in SGRY?

As of Q2 2026, Pentwater Capital Management LP holds 11.63M shares of SGRY (SURGERY PARTNERS INC), valued at $195.38M, representing 2.27% of its reported portfolio and ranking #12.

Has Pentwater Capital Management LP been buying or selling SGRY?

In the latest 13F filing (Q2 2026), Pentwater Capital Management LP reduced its position in SGRY. The position peaked in Q3 2025 at 11.68M shares.

Which other funds hold SGRY?

Other major institutional holders of SGRY include BAIN CAPITAL INVESTORS LLC, KING STREET CAPITAL MANAGEMENT, L.P., Davidson Kempner Capital Management, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.